NumerixS Investment Technologies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

NumerixS Investment Technologies’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-600	Closed	-$118K	–	340
2020 Q2	$118K	Sell	600 -100	-14%	-$20.7K	0.03%	539
2020 Q1	$137K	Buy	+700	New	+$151K	0.07%	340
2019 Q4	–	Sell	-100	Closed	-$15K	–	1115
2019 Q3	$15K	Buy	+100	New	+$16.4K	﹤0.01%	907
2018 Q2	–	Sell	-800	Closed	-$80K	–	1204
2018 Q1	$80K	Buy	800 +600	+300%	+$64.7K	0.02%	713
2017 Q4	$19K	Buy	+200	New	+$18.9K	﹤0.01%	1004
2017 Q3	–	Sell	-2,200	Closed	-$168K	–	1224
2017 Q2	$168K	Buy	+2,200	New	+$185K	0.02%	693

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

NumerixS Investment Technologies's LKFT Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 600 shares — an estimated $118K sold.

NumerixS Investment Technologies first reported a position in LKFT in Q2 2017 and held it in 6 quarters. The position peaked at $168K in Q2 2017. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

NumerixS Investment Technologies reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 600 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $118K.
NumerixS Investment Technologies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 6 quarters.
NumerixS Investment Technologies's Lakefront Biotherapeutics American Depositary Shares position peaked at $168K in Q2 2017.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.